Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06752603

A Clinical Study of ONO-1110 in Patients With Hunner Type Interstitial Cystitis

A Phase IIa, Randomized, Double-blind, Placebo Controlled, Parallel Group, Multi-center Trial to Evaluate the Efficacy and Safety of ONO-1110 in Patients With Hunner Type Interstitial Cystitis

Status
Active Not Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Ono Pharmaceutical Co., Ltd. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To Evaluate the Efficacy and Safety of ONO-1110 in Patients with Hunner Type Interstitial Cystitis

Conditions

Interventions

TypeNameDescription
DRUGONO-1110ONO-1110 tablets once a day
DRUGPlaceboPlacebo tablets once daily

Timeline

Start date
2025-04-02
Primary completion
2026-09-01
Completion
2026-11-01
First posted
2024-12-30
Last updated
2026-03-30

Locations

20 sites across 1 country: Japan

Source: ClinicalTrials.gov record NCT06752603. Inclusion in this directory is not an endorsement.